What are the implications of low Anti-Müllerian Hormone (AMH) levels and can they be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Low Anti-Müllerian Hormone (AMH) levels are associated with a higher risk of miscarriage, and while there are no proven medical treatments to increase AMH levels, women with low AMH may consider fertility preservation and assisted reproductive technologies. The implications of low AMH levels are significant, as they indicate diminished ovarian reserve, suggesting fewer remaining eggs and potentially reduced fertility 1. According to a systematic review and meta-analysis published in Human Reproduction Update in 2021 1, women with low AMH levels have a significantly higher rate of miscarriage compared to those with medium or high serum AMH concentrations.

Key Considerations

  • Low AMH levels are associated with a higher risk of miscarriage, with a pooled odds ratio of 1.35 (95% CI, 1.10–1.66; P = 0.004) 1
  • Women with low AMH may consider timely family planning, fertility preservation through egg freezing, or assisted reproductive technologies like IVF
  • Some fertility specialists may recommend supplements such as DHEA, CoQ10, or vitamin D, though evidence for their effectiveness is limited
  • Lifestyle modifications, including maintaining a healthy weight, avoiding smoking, reducing alcohol consumption, and managing stress, may support overall reproductive health

Fertility Options

  • Women with low AMH should consult with a reproductive endocrinologist to discuss personalized fertility options and realistic expectations
  • Individual responses to fertility treatments vary considerably, even with diminished ovarian reserve
  • Age remains the most significant factor affecting fertility outcomes, and women with low AMH should be aware of this when planning their fertility 1

From the Research

Implications of Low Anti-Müllerian Hormone (AMH) Levels

  • Low AMH levels are associated with a lower ovarian reserve, which can impact fertility and reproductive health 2, 3.
  • AMH levels can be affected by various factors, including contraceptive use, with some methods showing a significant decrease in AMH levels compared to non-users 4.
  • Obesity has been suggested to potentially impact AMH levels, although the current evidence is limited and inconclusive 5.
  • High AMH levels can be predictive of poor response to certain fertility treatments, such as clomiphene citrate, in women with polycystic ovarian syndrome (PCOS) 6.

Treatment Options for Low AMH Levels

  • There is no direct treatment for low AMH levels, but addressing underlying factors such as obesity or switching to a different contraceptive method may help 4, 5.
  • Fertility treatments, such as in vitro fertilization (IVF), may be more challenging for women with low AMH levels, but individualized approaches can be developed to optimize outcomes 2, 3.
  • AMH levels can be used to guide fertility treatment decisions, such as determining the optimal dosage of follicle-stimulating hormone (FSH) 3.

Importance of AMH Testing

  • AMH testing can provide valuable information about ovarian reserve and fertility potential 2, 3.
  • AMH levels can be used to predict the risk of poor response or ovarian hyperstimulation syndrome in fertility treatments 3.
  • However, the lack of international standardization of AMH assays can limit the comparison of results and interpretation of AMH values in a clinical setting 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Journal of assisted reproduction and genetics, 2020

Research

Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

The Journal of clinical endocrinology and metabolism, 2020

Research

The role of anti-Müllerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.